KR20180052286A - Facial mask - Google Patents
Facial mask Download PDFInfo
- Publication number
- KR20180052286A KR20180052286A KR1020160149423A KR20160149423A KR20180052286A KR 20180052286 A KR20180052286 A KR 20180052286A KR 1020160149423 A KR1020160149423 A KR 1020160149423A KR 20160149423 A KR20160149423 A KR 20160149423A KR 20180052286 A KR20180052286 A KR 20180052286A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- face mask
- present
- mask composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
A face mask and a method for manufacturing the same are provided. The face mask comprises 20-50 parts by weight of RADIX ASTRAGALI, 40-80 parts by weight of coix seed and 40-80 parts by weight of PORIA ALBA. A useful effect of the present invention is that the ingredients of the traditional Chinese medicine can interact with each other to produce a synergistic effect, and the face blood circulation can be promoted, so that waste products and toxic gases can be absorbed.
Description
The present invention relates to the field of skin care And more particularly to the field of facial masks.
The face is more easily exposed to the surrounding environment than other body parts and is therefore more often suffered by the effects caused by wind, sunburn, electromagnetic radiation, dust, and the like. Due to the diverse skin characteristics of different humans, some facial problems can occur and people with problems may feel embarrassed or inconvenienced. More seriously, these problems can have a negative impact on a person's job, marriage, and so on.
Facial masks are becoming very popular for alleviating or eliminating facial problems. However, most face masks contain heavy metal or phosphorus ingredients, which can damage the skin of a person when used for long periods of time.
Thus, to reduce damage to the skin while being suitable for prolonged use It is necessary to develop a facial mask using safe natural ingredients.
It is an object of the present invention to provide a Thereby providing an effective facial mask.
The According to one aspect, there is provided a face mask comprising 20-50 parts by weight of RADIX ASTRAGALI, 40-80 parts by weight of coix seed, and 40-80 parts by weight of PORIA ALBA.
A useful effect of the present invention is that the ingredients of the traditional Chinese medicine can interact with each other to produce a synergistic effect, and the face blood circulation can be promoted, so that waste products and toxic gases can be absorbed.
Traditional Chinese medicine facial masks facilitate effective penetration of nutrients into the deep layers of the skin and can also be used to moisturize, moisturize, whiten, wrinkle, wrinkle, anti-aging, anti-inflammation, Lt; / RTI >
In addition, the various components within the facial mask provided by the present invention may exhibit interactions that ensure long-term quality.
Finally, the face mask provided by the present invention contains only natural plants and does not contain any chemical components. Thus, the present invention is beneficial to human skin and scarcely causes damage.
Examples of the present invention
The following examples further illustrate and illustrate embodiments within the scope of the present invention. The examples are presented for illustrative purposes only, and should not be construed as limiting the invention since many modifications thereto are possible without departing from the spirit and scope of the invention.
20-50 parts by weight of sulfur, 40-80 parts by weight of rosemary, and 40-80 parts by weight of rosemary.
According to a first embodiment of the present invention, the facial mask composition comprises 20 parts by weight of an emerald period, 40 parts by weight of yulmu, and 40 parts by weight of white nectar.
According to a second embodiment of the present invention, the face mask composition comprises 50 parts by weight of sulfur, 80 parts by weight of iridium, and 80 parts by weight of rosemary.
According to a third embodiment of the present invention, the facial mask composition comprises 20 parts by weight of an emerald period, 80 parts by weight of yulmu, and 40 parts by weight of white nectar.
According to a fourth embodiment of the present invention, the face mask composition comprises 50 parts by weight of sulfur, 40 parts by weight of iridium, and 80 parts by weight of rosemary.
According to a fifth embodiment of the present invention, the face mask composition comprises 35 parts by weight of sulfur, 60 parts by weight of iridium, and 60 parts by weight of rosemary.
According to a sixth embodiment of the present invention, the facial mask composition comprises 20 parts by weight of an emerald period, 60 parts by weight of iridium, and 40 parts by weight of white rose.
According to a seventh embodiment of the present invention, the face mask composition comprises 50 parts by weight of sulfur, 60 parts by weight of iridium, and 80 parts by weight of rosemary.
According to an eighth embodiment of the present invention, the face mask composition comprises 35 parts by weight of sulfur, 40 parts by weight of iridium, and 60 parts by weight of rosemary.
According to a ninth embodiment of the present invention, the face mask composition comprises 35 parts by weight of sulfur, 80 parts by weight of iridium, and 60 parts by weight of rosemary.
According to a tenth embodiment of the present invention, the face mask composition comprises 25 parts by weight of sulfur, 45 parts by weight of iris, and 45 parts by weight of rosemary.
According to an eleventh embodiment of the present invention, the face mask composition comprises 45 parts by weight of sulfur, 65 parts by weight and 55 parts by weight of Baekbokyeol.
According to a twelfth embodiment of the present invention, the face mask composition comprises 40 parts by weight of sulfur, 65 parts by weight and 70 parts by weight of white roots.
According to a thirteenth embodiment of the present invention, the face mask composition comprises 30 parts by weight of sulfur, 65 parts by weight, and 60 parts by weight of C. baesulgi.
The term "parts by weight" Quot; means the ratio between each component or element and does not imply a ratio to the total weight.
Manufacturing method
The materials or components described above can be obtained commercially or obtained by conventional processing methods, for example, these materials can be obtained by drying the material and pulverizing it into a powder having an average particle size of 20-30 mesh .
The production of traditional herbal medicine extracts includes the following operations.
The components are mixed and ground into a powder and ethanol is used as a solvent to perform supercritical carbon dioxide extraction on the powder at 60 占 폚 under 30 MPa for 0.5 hour. In particular, the amount of ethanol is 2 ml per g of the powder, the analytical pressure is 10 MPa, and the analysis temperature is 20 ° C.
Concentration under reduced pressure is carried out, and ethanol is recovered to obtain an ethanol extract concentrate.
After running the supercritical carbon dioxide extraction, the residue is boiled twice, wherein the residue is first boiled using 8-10 times water for 30-50 minutes; Secondarily boil the residue using 9-12 times water for 80-90 minutes.
The boiled liquid is filtered and the filtered liquid is combined and concentrated to a liquid having a density of 1.3-1.5 at 50 < 0 > C.
A liquid having a density of 1.3-1.5 is dried to obtain an extract.
Extracts are enriched with macroporous adsorbent resins and in particular the extracts are diluted with a predetermined amount of water and mixed with the same volume of D-101 macroporous adsorbent resin and mixed with D-101 or AB-8 type and other Is loaded onto a macroporous adsorbent resin of non-polar, weak polarity or medium polarity. The loading volume is calculated using the production volume to resin ratio of 1: 3. After 15 minutes of static adsorption, elution is carried out using 10 volumes of ethanol at different densities, and 60% -70% ethanol elution solution is collected to obtain a brown powder.
The powder is also mixed with brown oil-like mucilage obtained through supercritical carbon dioxide extraction, thereby obtaining a transitional herbal extract.
Using a UVB-induced pigmentation model, traditional herbal medicine is administered as follows.
Three separate areas (2 cm x 2 cm) of each of the guinea pigs are selected, the long hair of each guinea pig is cut with scissors, and the short hair is cleanly pushed with an electric razor. The region is then irradiated with a radiation therapy device of the SS-04B type with a UVB light source having a spectral peak between 310-315 nm. Irradiation amount of 200 mJ / cm 2 for 20 minutes every day to the area, and irradiation in order to obtain the amount of the cumulative dose of 2800 mJ / cm 2 is continued for two weeks. After 2 hours of irradiation, the drug is administered, and the drug administration is continued for 2 weeks after the completion of the irradiation. Then, the tissue of the face is taken for pathological examination.
Samples are divided into three groups to observe the number of melanin-containing cells and DOPA-positive cells.
Group 1: Reference group containing the back skin of normal guinea pigs not irradiated by UVB;
Group 2: a group comprising the back skin of guinea pigs which is examined by UVB but is not coated with the traditional herbal medicine of the present invention;
Group 3: Groups containing the back skin of guinea pigs coated with traditional herbal drugs of Examples 1-13 after UVB irradiation (concentrations are 0.5 and 1 mg / ml, respectively).
Dyeing process
1) HE staining: Skin samples (2 cm x 2 cm) of the back of guinea pigs are HE-stained with conventional paraffin sections.
2) Schmorl dyeing:
a. The sections are washed with water;
b. Then, the slice was treated with a mixture of 40 ml of FeCl 3 solution of 0.04 mol / L, 6 ml of potassium ferricyanide solution of 0.04 mol / L and 6 ml of distilled water for 10 minutes;
c. The sections are washed with running water.
Results: Melanocytes are stained with brown and black particles.
3) Imokawa dyeing
a. Skin samples (2 cm x 2 cm) were taken from the back of guinea pigs, washed with PBS liquid (pH 6.8) at a concentration of 0.1 mol / L and incubated with sodium bromide at a concentration of 1 mol / Lt; / RTI >
b. Separate cuticle and dermis of skin.
c. The corn flakes are adjusted for 30 minutes with a cold neutral formalin solution at a concentration of 3.33 mol / L (10%) and then washed twice with 0.1 mol / L PBS solution (pH 6.8).
d. Then, the corn flakes are stained with a 0.1 mol / L PBS solution for 5 hours.
Results: Melanocytes are stained with black and brown particles.
Optical microscope observation
1) Count of Melanin Particle Cells: The number of melanin particle cells per 1 mm 2 of the zinor stromal progression in each sample was counted by a net eyepiece micrometer single blind method under high magnification lens;
2) Count of DOPA-positive cells: Count the number of DOPA-positive melanocytes per 1 mm 2 of the epithelium of each sample in Imocai and the progress of dyeing, using a single eyelid microscope method with a high magnification lens.
Table 1 shows the average number of melanin particle and DOPA positive melanocyte cells in the unirradiated group, the irradiated group, and the group to which the facial mask according to Example 1-13 of the present invention was applied.
Compared to the reference group, the second group exposed under UVB irradiation has a much higher number of melanin particle cells and DOPA positive melanocyte cells.
After the application of Examples 1-13 of the present invention, the number of melanin particle cells and DOPA positive melanocytes in the peel was significantly reduced to a level very close to the reference group. Obviously, the present invention exhibits a good effect in skin whitening and brown anti-elimination.
In particular, Example 5 shows the best effect among Examples 1-13 when decreasing the number of melanin particle cells and DOPA-positive melanocyte cells, and sometimes this embodiment reaches a level very close to the reference group.
Further, in Examples 1, 11 and 12 shows relatively good performance as compared to the other embodiments except for Example 1. [
The facial mask of the present invention is suitable for topical application to human skin, especially facial skin. The use of the present invention provides skin conditioning benefits, such as smoothness, softness, and moist feel, by the deposition and permeation of various ingredients.
The benefits of the present invention are provided by the application of the mask compositions of the present invention in the context of certain benefit agents, such as long-term whitening agents and skin benefit agents, included in the emulsified liquid compositions. The mask composition of the present invention is particularly beneficial when delivering nutrients and other benefit agents into the skin.
The use of the mask composition of the present invention while using an insoluble substrate as a delivery means over a long period of time compared to when the liquid composition is applied to the skin without the use of an insoluble substrate results in better distribution and deposition of such benefit agents, ≪ / RTI > is believed to provide better permeation of the beneficial agent that can be used.
Further, when an insoluble substrate having low air permeability is used, more effective permeation of the skin benefit agent into the skin is expected. It is also believed that the mask compositions of the present invention provide emotional benefits to the user, such as a refreshing feeling, and a comfortable feeling, in use.
In a preferred embodiment, the mask composition comprises: (a) applying a mask composition to a majority of the area of the facial skin; (b) an optional Maintaining the mask composition on the facial skin for a time not longer than the time until the portion is dried; (c) removing the mask composition from the facial skin; (d) treating the facial skin by removing the remaining liquid composition remaining on the facial skin.
The mask composition is immersed in an aqueous liquid composition so that the mask is fit to the facial skin by allowing it to remain in the skin. Press the mask against the facial skin using your fingertips to better fit your face and distribute the nutrients and other skin benefit agents evenly.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160149423A KR20180052286A (en) | 2016-11-10 | 2016-11-10 | Facial mask |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160149423A KR20180052286A (en) | 2016-11-10 | 2016-11-10 | Facial mask |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180052286A true KR20180052286A (en) | 2018-05-18 |
Family
ID=62453904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160149423A KR20180052286A (en) | 2016-11-10 | 2016-11-10 | Facial mask |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20180052286A (en) |
-
2016
- 2016-11-10 KR KR1020160149423A patent/KR20180052286A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108524414A (en) | A kind of more effect Chinese pitted skin films and its preparation process | |
KR101854840B1 (en) | Mask pack comprising pozzolan | |
CN108553371A (en) | Have effects that skin care compositions that antiallergic is releived and preparation method and application | |
JP7075177B2 (en) | Cosmetics | |
KR20180029578A (en) | Facial mask | |
CN103222936B (en) | Dermatologic preparation composition containing Semen Nelumbinis extract | |
KR20180000553A (en) | Cosmetics composition | |
KR20180033673A (en) | Facial mask | |
KR20180052286A (en) | Facial mask | |
KR20180029579A (en) | Facial mask | |
KR20180044538A (en) | Facial mask | |
DK201670750A1 (en) | Facial mask compositions | |
KR20180065111A (en) | Facial mask | |
KR20180035371A (en) | Facial mask | |
KR20180000513A (en) | Cosmetics Composition | |
KR20180022430A (en) | Facial mask | |
KR20180016788A (en) | Facial mask | |
KR20170136959A (en) | Facial mask compositions | |
KR20180050028A (en) | Facial mask | |
KR20180033859A (en) | Facial mask | |
KR20180036136A (en) | Facial mask | |
KR20180032297A (en) | Facial mask | |
KR20180036186A (en) | Facial mask | |
CN107822994A (en) | A kind of anti-inflammatory anti-itch composition and the skin care item comprising said composition | |
KR20180031171A (en) | Facial mask |